Due to the fact that CART cells recognize and eradicate tumor cells independently of the MHC, some of the main ways that tumors evade MHC-restricted T cell recognition, such as the downregulation of human leukocyte antigen (HLA) class I molecules and improper antigen processing, have no effect on the target cell recognition. The gene discussed is HLA-C; the disease is neoplasm.